Miloš Pavić

Miloš Pavić is an experienced professional in market access strategy and precision medicine, currently serving as Insights Leader at AstraZeneca since April 2024. Prior experience includes consulting roles at Envision Pharma Group and Two Labs from 2021 to 2023, focusing on global value and access strategy, as well as market access and pricing strategy. Miloš held the position of HEMAR Manager with The Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2020 and was Head of Healthcare Events and Board Member at SDA Bocconi from 2018 to 2020. Earlier roles include consultative work in market access and a specialist in endocrinology diabetes and rheumatology and cardiology at Merck and MSD respectively, alongside an initial role as a pharmacist at Vanex Pharmacy. Miloš Pavić's education includes a degree in International Healthcare Management, Economics and Policy from SDA Bocconi and a Pharm.D. from the University of Niš.